Every material Form 8-K BlueLinx Holdings Inc. has filed with the SEC since May 19, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
BlueLinx reported fiscal third-quarter 2026 net sales of $813 million, up 8.5% from a year earlier, with gross margin up to 16.1%. The company swung to a net loss of $0.6 million, or $0.07 per share, from net income of $1.7 million, or $0.20 per share, a year earlier, though adjusted EPS rose to $0.68 from $0.45. Shareholders also face a Fourth Quarter outlook that expects average daily sales volumes to be slightly lower than the prior quarter.
Net sales of $813 million, up 8.5%, with gross margin of 16.1% versus 14.4% a year earlier
Net loss of $0.6 million, or $0.07 per share, compared with net income of $1.7 million, or $0.20 per share, in third quarter 2025
Adjusted EBITDA of $31.7 million, up 42% from the prior year, and operating cash flow of $44.7 million, down from $58.6 million
Fourth quarter 2026 outlook: specialty gross margin of 17.5% to 18.5%, structural gross margin of 9.0% to 10.0%, and slightly lower average daily sales volumes
BlueLinx reported fiscal second quarter 2026 net sales of $814 million, up 4.4% from a year earlier, with net income of $6.4 million, or $0.81 per diluted share, versus $0.54 a year earlier. Results included a $7.2 million benefit from an import duty-related item, and the company gave specialty and structural product gross margin ranges for the third quarter.
Net sales $814 million, up $34 million or 4.4%; gross margin 17.2% vs. 15.3% a year earlier
Net income $6.4 million, or $0.81 diluted EPS, vs. $4.3 million, or $0.54; adjusted diluted EPS $1.15 vs. $0.70
Gross profit included a $7.2 million import duty-related benefit; excluding it, gross margin would have been 16.3%
Third quarter outlook: specialty gross margin 18.0% to 19.0%; structural gross margin 8.5% to 9.5%
At its May 14, 2026 annual meeting, BlueLinx stockholders re-elected eight of nine directors and approved the auditor ratification, advisory pay resolution and 2021 Plan amendment. Director Mitchell Lewis did not receive a majority of votes cast, which under the company's bylaws led him to tender a resignation offer, but the board unanimously rejected it and he remains on the board. Shareholders should note the board's decision on a director who was opposed by ISS and Glass Lewis.
Lewis received 2,604,527 for votes and 3,325,567 against, and was the only nominee not re-elected by a majority
The board unanimously rejected Lewis's resignation offer, and he recused himself from the deliberations
Lewis will be replaced as Chairman of the Nominating Committee by Marietta Edmunds Zakas
Ernst & Young LLP ratification received 7,122,739 for votes out of 7,133,560 shares represented
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every BlueLinx Holdings Inc. filing is on SEC EDGAR ↗. 8-K briefs of other companies →